A detailed history of Edgewood Management LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Edgewood Management LLC holds 24,060 shares of PRTA stock, worth $337,802. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,060
Previous 24,060 -0.0%
Holding current value
$337,802
Previous $496,000 18.95%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$52.05 - $65.0 $48,927 - $61,100
-940 Reduced 3.76%
24,060 $1.45 Million
Q4 2020

Feb 12, 2021

BUY
$10.12 - $13.94 $252,999 - $348,500
25,000 New
25,000 $300,000

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $659M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Edgewood Management LLC Portfolio

Follow Edgewood Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edgewood Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Edgewood Management LLC with notifications on news.